Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
23,974,672
Share change
-107,062
Total reported value
$1,951,921,924
Put/Call ratio
128%
Price per share
$81.47
Number of holders
178
Value change
-$4,134,242
Number of buys
83
Number of sells
71

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2020

As of 31 Dec 2020, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 178 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,974,672 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., IRIDIAN ASSET MANAGEMENT LLC/CT, RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, ALETHEA CAPITAL MANAGEMENT, LLC, PICTET ASSET MANAGEMENT LTD, BAKER BROS. ADVISORS LP, and CITADEL ADVISORS LLC. This page lists 178 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.